SINGLE CAUSE SINGLE CURE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

TRAVIS CHRISTOFFERSON

Phone

6053436199

Tax Period

2022-01-01 to 2022-12-31

SINGLE CAUSE SINGLE CURE, founded in 2013, is a small nonprofit in the Medical Research sector that reported $554K in total revenue in fiscal year 2022. Revenue surged 51% from the prior year, signaling strong growth momentum. Expenses of $479K left a modest 13% surplus.

Mission

OUR MISSION IS TO CURE CANCER THROUGH METABOLIC THERAPIES SUCH AS THE KETOGENIC DIET, HYPERBARIC OXYGEN, AND RE-PURPOSED DRUGS. OUR GOAL IS TO FUND THE RESEARCH THAT MAY DEMONSTRATE THE EFFICACY OF THESE THERAPIES SO THEY MAY BE INCORPORATED INTO THE ONCOLOGY CLINIC FOR EVERYONE.

Program Service Accomplishments

Program 1

Expenses: $474,061

IN 2022, THE FOUNDATION FOR METABOLIC CANCER THERAPIES OBTAINED RESULTS FROM THE FORMULATED MEBENDAZOLE GRANT AND FROM THE CONTINUATION OF THE GRANT TO COMBINE METABOLIC ACTIVE DRUG/DIET COMBINATIONS...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $548,676

Program Service Revenue $0

Investment Income $5,300

Other Revenue $0

TOTAL REVENUE $553,976

Expense Breakdown

Grants Paid $473,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $474,061

Other Expenses $6,390

TOTAL EXPENSES $479,390

Year-over-Year Comparison

	2022	2021	Change
Revenue	$553,976	$365,891	+0.5%
Expenses	$479,390	$190,300	+1.5%
Net Income	$74,586	$175,591	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TRAVIS CHRISTOFFERSON	CHIEF SCIENC	10.00	Officer Director	$0	$0	$0
CABOT-ANN CHRISTOFFERSON	SECRETARY	2.00	Officer Director	$0	$0	$0
STEVE COAST	TREAS. (THRU	2.00	Officer Director	$0	$0	$0
LARRY CHRISTOFFERSON	TREAS. (FROM	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$553,976	$479,390	$866,652	$74,586
2021	$365,891	$190,300	$807,975	$175,591
2020	$279,175	$103,039	$628,606	$176,136
2019	$315,393	$130,002	$413,455	$185,391
2018	$243,490	$249,881	$228,064	$-6,391